Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous L-arginine-dependent mechanism

British Journal of Pharmacology

Volumn 119, Issue 5, 1996, Pages 1063-1071

  Peng, W ^a   Hucks, D ^a   Priest, R M ^a   Kan, Y M ^a   Ward, J P T ^a  

^a St Thomas' Campus   (United Kingdom)

Author keywords

Endothelium; L arginine; Ligustrazine; Nitric oxide; Nitric oxide synthase; Pulmonary artery; Tetramethylpyrazine

Indexed keywords

ARGININE; LYSINE; METHYLENE BLUE; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM ION; PROSTAGLANDIN F2 ALPHA; TETRAMETHYLPYRAZINE; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CHINA; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM;

EID: 0029910095     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15778.x     Document Type: Article

References (30)

1. BAYDOUN, A.R., EMERY, P.W., PEARSON, J.D. & MANN, G.E. (1990). Substrate dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem. Biophys. Res. Commun., 173, 940-948.
2. BEIJING RESEARCH INSTITUTE OF THE PHARMACEUTICAL INDUSTRY. (1977a). Research on the active ingredients of Ligustrium wallichii Franchat. I. Extraction, separation, and chemical characterisation. Chin. Med. J., 7, 420-423.
3. BEIJING RESEARCH INSTITUTE OF THE PHARMACEUTICAL INDUSTRY. (1977b). Research on the active ingredients of Ligustrium wallichii Franchat. III Clinical (218 cases) use of Ligustrazine in the treatment of hypoxaemic cerebral vascular diseases. Chin. Med. J., 8, 467-469.
4. 2+-dependent nitric oxide synthase in bovine aortic endothelial cells. Am. J. Physiol., 269, C757-C765.
5. CAI, Y.N. & BARER, G.R. (1989). Effect of ligustrazine on pulmonary vascular changes induced by chronic hypoxia rats. Clin. Sci., 77, 515-520.
6. CAI, Y.N., BEE, D. & BARER, G.R. (1989). Pulmonary vasodilator action of ligustrazine, active principle of a traditional Chinese remedy, in rats and ferrets. Proc. Chin. Acad. Med. Sci.s Peking Union Med. Coll., 4, 147-152.
7. CAO, W., LUO, W. & GUO, Z. (1994). [Effects of ligustrazine and nitroglycerine on acute hypoxic pulmonary hypertension in anesthetized dogs]. [Chinese]. Chung-Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Acad. Med. Sin., 16, 79-83.
8. CHEN, K.J. & CHEN, K. (1992). Ischemic stroke treated with Ligusticum chuanxiong. [Review]. Chin. Med. J. Peking, 105, 870 873.
9. KWAN, C.Y. (1994). Plant-derived drugs acting on cellular Ca2+ mobilization in vascular smooth muscle: tetramethylpyrazine and tetrandrine. Stem Cells, 12, 64 67.
10. KWAN, C.Y., DANIEL, E.E. & CHEN, M.C. (1990). Inhibition of vasoconstriction by tetramethylpyrazine: does it act by blocking the voltage-dependent Ca channel? J. Cardiovasc. Pharmacol., 15, 157-162.
11. KWAN, C.Y., GASPAR, V., SHI, A.G., WANG, Z.L., CHEN, M.C., OHTA, A. & CRAGOE, E.J. JR, (1991). Vascular effects of tetramethylpyrazine: direct interaction with smooth muscle alpha-adrenoceptors. Eur. J. Pharmacol., 198, 15-21.
12. LEACH, R.M., ROBERTSON, T.P., TWORT, C.H. & WARD, J.P.T. (1994). Hypoxic vasoconstriction in rat pulmonary and mesenteric arteries. Am. J. Physiol., 266, L223-L231.
13. LEACH, R.M., TWORT, C.H., CAMERON, I.R. & WARD, J.P.T. (1992). A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. Clin. Sci., 82, 55-62.
14. LI, Y.J., WU, J.X., YU, X.J. & YAN, Y.F. (1994). Protective effect of tetramethylpyrazine against damages of aortic endothelial cells elicited by low-density lipoproteins. Acta Pharmacol. Sin., 15, 407 410.
15. LIN, C.I., WU, S.L., TAO, P.L., CHEN, H.M. & WEI, J. (1993). The role of cyclic AMP and phosphodiesterase activity in the mechanism of action of tetramethylpyrazine on human and dog cardiac and dog coronary arterial tissues. J. Pharmac. Pharmacol., 45, 963-966.
16. LIU, S.F., BARNES, P.J. & EVANS, T.W. (1996). Time course of lipopolysacharide-induced inducible nitric oxide synthase mRNA expression in the rat in vivo. Am. J. Resp. Crit. Care Med., 153, A186.
17. LIU, S.F., CAI, Y.N., EVANTS, T.W., MCCORMACK, D.G., BARER, G.R. & BARNES, P.J. (1990). Ligustrazine is a vasodilator of human pulmonary and bronchial arteries. Eur. J. Pharmacol., 191, 345-350.
18. LIU, S.M. & TANG, T.Q. (1994). [Clinical and experimental studies of feiyaning in treating pulmonary arterial hypertension in cor pulmonale]. [Chinese]. Chung-Kuo Chung Hsi i Chieh Ho Tsa Chih, 14, 469-473.
19. LIU, S.Y. & SYLVESTER, D.M. (1994). Antiplatelet activity of tetramethylpyrazine. Thromb. Res., 75, 51-62.
20. MAGEE, F., WRIGHT, J.L., WIGGS, B.R. & HOGG, J.C. (1988). Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax, 43, 183-189.
21. ODDOY, A., BEE, D., EMERY, C. & BARER, G.R. (1991). Effects of ligustrazine on the pressure/flow relationship in isolated perfused rat lungs. Eur. Respir. J., 4, 1223-1227.
22. PENG, W. & DUAN, S.F. (1991). Effects of ligustrazine controlled release capsule in chronic pulmonary heart disease. J. Tongji Med. Univer., 11, 101-105.
23. PENG, W. & DUAN, S.F. (1993). [Effects of ligustrazine controlled release capsule on hemorrheology in patients with cor pulmonale]. [Chinese]. Chung-Hua Nei Ko Tsa Chih, 32, 37-39.
24. PENG, W., DUAN, S.F., YU, X. & HONG, Y. (1993). The study of dose-effect correlation and pharmacokinetics of ligustrazine in COPD patients with pulmonary hypertension. Am. Rev. Respir. Dis., 147, A138.
25. POLLOCK, J.S., FOSTERMANN, U., MITCHELL, J.A., WARNER, T.D., SCHMIDT, H.H.H.W., NAKANE, M. & MURAD, F. (1991). Purification and characterisation of particulate endothelium derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 88, 10480-10484.
26. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1990). Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 87, 10043-10047.
27. REBICH, S., DEVINE, J.O. & ARMSTEAD, W.M. (1995). Role of nitric oxide and cAMP in β-adrenoceptor-induced pial artery vasodilation. Am. J. Physiol., 268, H1071-H1076.
28. SUTTER, M.C. & WANG, Y.X. (1993). Recent cardiovascular drugs from Chinese medicinal plants. [Review]. Cardiovasc. Res., 27, 1891-1901.
29. 2+-channel blocker"? Chin. J. Integr. Trad. West. Med., 5, 291-294.
30. ZHANG, Z.H., YU, S.Z., WANG, Z.T., ZHAO, B.L., HOU, J.W., YANG, F.J. & XIN, W.J. (1994). Scavenging effects of tetramethylpyrazine on active oxygen free radicals. Acta Pharmacol. Sin., 15, 229-231.